Overview
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $1,588,243 | |
| Management board pay | $80,494 | |
| Parent company | Abbott Holdings Poland Sp. z o.o. |
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 91 days for 2021). All were audited by a statutory auditor.
- 202507/08/2026
- 202415/07/2025
- 202314/07/2024
- 202211/07/2023
- 202114/10/2022
- 202030/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Public procurement
168 tenders recorded as contractor: 60 national ($6,996,846) and 108 EU ($100,498,083), and 1 as contracting authority.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Nov 12, 2026 | Supply of reagents for NGS, QPCR, mass spectrometer, cell selection, ammonia determination and IHC staining, together with lease of apparatus for nio-pib Oddział w Gliwicach | $13,258$13,258 | Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Oddział w Gliwicach | |
| Nov 6, 2026 | D-45/2026 Supply of reagents together with the lease of integrated analyzers for the biochemical-immunological system for the needs of cla at Szpital Wielospecjalistyczny im dr. Ludwika Błażka w Inowrocławiu | $1.5M$1,502,049 | Szpital Wielospecjalistyczny Im. Dr. Ludwika Błażka w Inowrocławiu | |
| Nov 3, 2026 | Supply of reagents 5 | $688.3K$688,280 | Samodzielny Publiczny Szpital Kliniczny Im.Andrzeja Mielęckiego Śląskiego Uniwersytetu Medycznego w Katowicach |
The company is the contractor in 67 public sector contracts, worth USD 39.85m in total. They were signed with 42 public buyers. The largest number (3) were signed with Uniwersytecki Szpital Kliniczny w Poznaniu.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 26, 2026 | Reagents | $554.88 | Szpital Specjalistyczny Ducha Świętego w Sandomierzu | |
| Oct 22, 2026 | Purchase of Optium Xido Neo glucose meter strips | $194.49 | Wojewódzki Zespół Specjalistyczny w Rzeszowie | |
| Oct 20, 2026 | Supply of reagents | $3,778,107 | Uniwersytecki Szpital Kliniczny w Białymstoku |
Abbott Laboratories Poland has been a party to 103 cases before the National Appeal Chamber (since 2008). It filed 62 appeals (16 upheld, 29 dismissed, 14 discontinued, 1 rejected). In 41 cases it joined the proceedings as a participant.
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| Sep 21, 2026 | Rejection of the tender | Dismissed | Wojewódzki Szpital Specjalistyczny w Legnicy | |
| Sep 7, 2026 | Error in price calculation | Dismissed | Miejski Szpital Zespolony w Olsztynie | |
| Jul 31, 2026 | Error in price calculation | Discontinued | Uniwersytecki Szpital Kliniczny w Poznaniu |
Trademarks
The company currently holds no active trademarks with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2004.
| Mark | Protected until | |
|---|---|---|
| DISNEMAR XYLO (word) | – | |
| Optium Omega | – | |
| GlukoLink | – | |
| MediSense. Możesz na nas liczyć. (word) | – | |
| Mark without a word element (figurative) | – |
Authorized Representatives
Manner of representation
Each of the members of the management board acting independently is authorized to represent the company, make declarations and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 221,728 | $5,989,411.13 | 31.609% | |
St. Jude Medical Luxembourg | 479,744 | $12,959,049.16 | 68.391% |
Beneficial owners
| Person | Rights |
|---|---|
Capital group
The company belongs to the Abbott Laboratories (United States) group, which is its direct owner. The group has 143 companies, 141 of them abroad.
| Name | Country |
|---|---|
| Abbott | |
| Abbott (Jiaxing) Nutrition CO. Ltd. | |
| Abbott AG | |
| Abbott Asia Holdings Limited | |
| Abbott Australasia PTY Ltd |
Bank accounts
Registered as a VAT taxpayer on 1998-03-01.
20 1880 0009 0000 0011 0252 6001
47 1880 0009 0000 0011 0252 6000
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 468.9KPLN 468,869 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 17, 2011 | Commercial Companies Code notice | |
| Nov 3, 2010 | Merger plan |
Public aid
No public aid cases recorded in the last 10 years.
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-02-24 | Procurement of rapid antigene tests for diagnostic of covid-19 | $6.1M$6,136,076 | 2.2.26 - Instrument for emergency support within the Union (ESI) |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Pfizer Trading Polska sp. z o.o. | $299,067,553.99 | pfizer.pl | ||
| Berlin-Chemie / Menarini Polska sp. z o.o. | $240,194,615.27 | berlin-chemie.pl | ||
| Bristol-Myers Squibb Polska sp. z o.o. | $230,722,737.87 | bms.com | ||
| Takeda Pharma sp. z o.o. | $246,400,594.27 | takeda.com | ||
| Natur Produkt Zdrovit sp. z o.o. | $205,379,396.79 | zdrovit.pl | ||
| Astellas Pharma sp. z o.o. | $220,199,081.58 | astellas.com | ||
| Bialmed sp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Roche Diagnostics Polska sp. z o.o. | $199,208,461.57 | roche.pl | ||
| Servier Polska Services sp. z o.o. | $157,143,144.15 | servier.pl | ||
| Angelini Pharma Polska sp. z o.o. | $119,629,315.69 | angelinipharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-11-06 | Share capital increase (22,172,800.00 PLN → 70,147,200.00 PLN) | |
| 2019-01-02 | Share capital reduction (29,500,300.00 PLN → 22,172,800.00 PLN) | |
| 2015-02-02 | Share capital reduction (34,877,900.00 PLN → 29,500,300.00 PLN) | |
| 2010-12-31 | Share capital increase (30,084,800.00 PLN → 34,877,900.00 PLN) | |
| 2009-12-04 | Address change (Postępu 18a, 02-676, Warszawa → Postępu 21b, 02-676, Warszawa) |
FAQ
Last updated: 2026-08-07